Related Experiment Videos
Neurofibromatosis type 2: a new mechanism of tumor suppression
1Centre Research in Neurosciences, McGill University, Montréal Québec, Canada.
Abstract:
Neurofibromatosis type 2 (NF2) is an autosomal dominant disease which predisposes primarily to CNS tumors such as schwannomas (vestibular and spinal), meningiomas, ependymomas and juvenile posterior lenticular opacities. Allelic losses on chromosome 22q first suggested the existence of a tumor suppressor on this autosome in accordance with Knudson's 'two hit' model. The gene was identified by positional cloning and found to encode a novel protein schwannomin (also known as merlin), with high sequence similarity to the band 4.1 family of proteins. This similarity suggested a new mechanism of tumor suppression since it was the first time a structural protein had been associated with a human tumor. Mutation analysis confirmed that inactivation of the NF2 gene occurred in NF2 tumors and a majority of sporadic schwannomas and meningiomas. Expression and functional studies have provided additional information on the possible involvement of this novel tumor suppressor in cell differentiation, embryogenesis and growth suppression.
Insights
Neurofibromatosis type 2 (NF2) is a genetic disorder causing tumors. The NF2 gene, encoding the schwannomin (merlin) protein, acts as a tumor suppressor, with its inactivation linked to NF2-related tumors.
Area of Science:
- Genetics and Oncology
- Molecular Biology
- Tumor Suppressor Genes
Background:
- Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder.
- It predisposes individuals to central nervous system (CNS) tumors, including schwannomas and meningiomas.
- Cytogenetic studies identified chromosome 22q deletions, suggesting a tumor suppressor gene.
Purpose of the Study:
- To identify the gene responsible for Neurofibromatosis type 2.
- To investigate the function of the identified tumor suppressor protein.
- To understand the role of the NF2 gene in sporadic schwannomas and meningiomas.
Main Methods:
- Positional cloning to identify the NF2 gene.
- Mutation analysis of the NF2 gene in tumors.
- Expression and functional studies of the schwannomin (merlin) protein.
Main Results:
- The NF2 gene was identified, encoding the schwannomin (merlin) protein, similar to band 4.1 proteins.
- Inactivation of the NF2 gene was confirmed in NF2-associated tumors.
- NF2 gene mutations were also found in a significant portion of sporadic schwannomas and meningiomas.
Conclusions:
- The NF2 gene product, schwannomin (merlin), is a novel tumor suppressor.
- Its mechanism of tumor suppression may involve its role as a structural protein.
- The NF2 gene is implicated in cell differentiation, embryogenesis, and growth suppression.